loadpatents
Patent applications and USPTO patent grants for Lee; Sung-Hyung.The latest application filed is for "heterodimeric antibodies that bind cd3 and tumor antigens".
Patent | Date |
---|---|
Heterodimeric Antibodies That Bind Cd3 And Tumor Antigens App 20220162343 - Bernett; Matthew J. ;   et al. | 2022-05-26 |
Heterodimeric Antibodies That Bind Somatostatin Receptor 2 App 20220162313 - Moore; Gregory ;   et al. | 2022-05-26 |
Heterodimeric Antibodies That Bind Cd3 And Tumor Antigens App 20220041757 - Bernett; Matthew J. ;   et al. | 2022-02-10 |
Heterodimeric antibodies that bind CD3 and tumor antigens Grant 11,225,528 - Bernett , et al. January 18, 2 | 2022-01-18 |
Heterodimeric antibodies that bind somatostatin receptor 2 Grant 11,225,521 - Moore , et al. January 18, 2 | 2022-01-18 |
Semiconductor Device App 20210375906 - KIM; Kang Min ;   et al. | 2021-12-02 |
Semiconductor device Grant 11,121,148 - Kim , et al. September 14, 2 | 2021-09-14 |
Heterodimeric antibodies that bind CD3 and tumor antigens Grant 11,111,315 - Bernett , et al. September 7, 2 | 2021-09-07 |
Semiconductor Device App 20210202516 - KIM; Kang Min ;   et al. | 2021-07-01 |
Heterodimeric Antibodies That Bind Cd3 And Tumor Antigens App 20210102003 - Bernett; Matthew J. ;   et al. | 2021-04-08 |
Heterodimeric antibodies that bind CD3 and tumor antigens Grant 10,913,803 - Bernett , et al. February 9, 2 | 2021-02-09 |
Heterodimeric antibodies that bind CD3 and tumor antigens Grant 10,889,653 - Bernett , et al. January 12, 2 | 2021-01-12 |
Heterodimeric Antibodies That Bind Enpp3 And Cd3 App 20200317814 - Rashid; Rumana ;   et al. | 2020-10-08 |
Trispecific Antibodies App 20190352416 - Moore; Gregory ;   et al. | 2019-11-21 |
Trispecific antibodies Grant 10,428,155 - Moore , et al. October 1, 2 | 2019-10-01 |
Heterodimeric Antibodies That Bind Somatostatin Receptor 2 App 20190248898 - Moore; Gregory ;   et al. | 2019-08-15 |
Heterodimeric Antibodies That Bind Cd3 And Tumor Antigens App 20190202938 - Bernett; Matthew J. ;   et al. | 2019-07-04 |
Heterodimeric antibodies that bind somatostatin receptor 2 Grant 10,316,088 - Moore , et al. | 2019-06-11 |
Heterodimeric antibodies that bind CD3 and tumor antigens Grant 10,259,887 - Bernett , et al. | 2019-04-16 |
Heterodimeric Antibodies That Bind Cd3 And Tumor Antigens App 20180282432 - Bernett; Matthew J. ;   et al. | 2018-10-04 |
Heterodimeric Antibodies That Bind Cd3 And Tumor Antigens App 20180223000 - Bernett; Matthew J. ;   et al. | 2018-08-09 |
Heterodimeric Antibodies That Bind Somatostatin Receptor 2 App 20180118827 - Moore; Gregory ;   et al. | 2018-05-03 |
Heterodimeric antibodies to CD3 X CD123 Grant 9,856,327 - Bernett , et al. January 2, 2 | 2018-01-02 |
Heterodimeric antibodies to CD3 X CD20 Grant 9,850,320 - Bernett , et al. December 26, 2 | 2017-12-26 |
Heterodimeric Antibodies To Cd3 X Cd123 App 20170081420 - Bernett; Matthew J. ;   et al. | 2017-03-23 |
Heterodimeric Antibodies To Cd3 X Cd123 App 20170081424 - Bernett; Matthew J. ;   et al. | 2017-03-23 |
Trispecific antibodies App 20160355600 - Moore; Gregory ;   et al. | 2016-12-08 |
Heterodimeric Antibodies That Bind Cd3 And Tumor Antigens App 20160355608 - Bernett; Matthew J. ;   et al. | 2016-12-08 |
Heterodimeric Antibodies Including Binding To Cd8 App 20160176969 - Bernett; Matthew J. ;   et al. | 2016-06-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.